Correlation Between PT Bank and Algernon Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PT Bank and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Bank and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Bank Central and Algernon Pharmaceuticals, you can compare the effects of market volatilities on PT Bank and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Bank with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Bank and Algernon Pharmaceuticals.

Diversification Opportunities for PT Bank and Algernon Pharmaceuticals

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between PBCRF and Algernon is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding PT Bank Central and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and PT Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Bank Central are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of PT Bank i.e., PT Bank and Algernon Pharmaceuticals go up and down completely randomly.

Pair Corralation between PT Bank and Algernon Pharmaceuticals

Assuming the 90 days horizon PT Bank is expected to generate 5.74 times less return on investment than Algernon Pharmaceuticals. But when comparing it to its historical volatility, PT Bank Central is 2.16 times less risky than Algernon Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  6.53  in Algernon Pharmaceuticals on November 4, 2024 and sell it today you would lose (0.78) from holding Algernon Pharmaceuticals or give up 11.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy96.81%
ValuesDaily Returns

PT Bank Central  vs.  Algernon Pharmaceuticals

 Performance 
       Timeline  
PT Bank Central 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PT Bank Central has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Algernon Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Algernon Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Algernon Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

PT Bank and Algernon Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PT Bank and Algernon Pharmaceuticals

The main advantage of trading using opposite PT Bank and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Bank position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.
The idea behind PT Bank Central and Algernon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios